Close

Tag: Drug

DeepCyte Launches World’s First Single-Cell Mechanistic Toxicity Atlas as Enterprise Pharma Pilots Advance

Proprietary training dataset spanning 300,000 cells and ~100 compounds positions DeepCyte to transform preclinical toxicology with mechanism-based prediction DeepCyte Inc., a techbio company building AI...

Merck Signs Voluntary Licensing Deals for Oral HIV Pill

Merck has entered into seven voluntary licensing agreements with generic manufacturers to produce and distribute lower-cost versions of alimatravir, its experimental once-monthly oral HIV...

Predictive Bioperformance Optimizing Drug Formulation

The pharmaceutical industry faces persistent challenges in the transition of drug candidates from discovery to clinical application. A primary obstacle is the accurate prediction...

MHRA Launches AI Sandbox to Accelerate Drug Development

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the launch of a new AI Sandbox programme designed to explore how artificial intelligence...

GSK Targets Nuvalent in $10.6 Billion Oncology Acquisition

GSK has agreed to acquire Nuvalent in a transaction valued at $10.6 billion, positioning the UK-based pharmaceutical company for its largest acquisition in more...

Sanofi and Owkin Partner to Co-Develop Agentic AI Tools for Drug Discovery

Sanofi has entered into a multi-year agreement with France-based agentic AI company Owkin to jointly develop next-generation AI-driven biopharma agents. The partnership includes a...

CytomX and Regeneron Expand Bispecific Cancer Therapy Collaboration with New Targets

CytomX Therapeutics and Regeneron Pharmaceuticals have expanded their ongoing research collaboration focused on developing tumor-activated bispecific cancer therapy candidates, broadening the scope of an...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »